TrialHepatology (Baltimore, Md.)2020

An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.

Juan P Arab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.